BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng J, Li C, Duan X, Liu F, Li A, Luo C, Jia L, Gan Y, Yan L, Zheng Y. PEGylation of lipophilic SN38 prodrug with DSPE-mPEG2000 versus cremophor EL: comparative study for intravenous chemotherapy. Drug Deliv 2019;26:354-62. [PMID: 30909751 DOI: 10.1080/10717544.2019.1587045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lv F, Fan X, Liu D, Song F. Photothermal agents based on small organic fluorophores with intramolecular motion. Acta Biomater 2022:S1742-7061(22)00398-1. [PMID: 35817339 DOI: 10.1016/j.actbio.2022.07.004] [Reference Citation Analysis]
2 Li X, Xia X, Zhang J, Adu-Frimpong M, Shen X, Yin W, He Q, Rong W, Shi F, Cao X, Ji H, Toreniyazov E, Wang Q, Yu J, Xu X. Preparation, Physical Characterization, Pharmacokinetics and Anti-Hyperglycemic Activity of Esculetin-Loaded Mixed Micelles. J Pharm Sci 2022:S0022-3549(22)00287-8. [PMID: 35780820 DOI: 10.1016/j.xphs.2022.06.022] [Reference Citation Analysis]
3 Li Y, Xie M, Jones JB, Zhang Z, Wang Z, Dang T, Wang X, Lipowska M, Mao H. Targeted Delivery of DNA Topoisomerase Inhibitor SN38 to Intracranial Tumors of Glioblastoma Using Sub-5 Ultrafine Iron Oxide Nanoparticles. Adv Healthc Mater 2022;:e2102816. [PMID: 35481625 DOI: 10.1002/adhm.202102816] [Reference Citation Analysis]
4 Wang Y, Luo C, Zhou S, Wang X, Zhang X, Li S, Zhang S, Wang S, Sun B, He Z, Sun J. Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies. Asian J Pharm Sci 2021;16:643-52. [PMID: 34849169 DOI: 10.1016/j.ajps.2021.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Xu MQ, Hao YL, Wang JR, Li ZY, Li H, Feng ZH, Wang H, Wang JW, Zhang X. Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo. Int J Nanomedicine 2021;16:7269-81. [PMID: 34737564 DOI: 10.2147/IJN.S331578] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Lei J, Zhang Q, Jin X, Lu H, Wang S, Li T, Sheng Y, Zhang F, Zheng Y. Drug Release from Disulfide-Linked Prodrugs: Role of Thiol Agents. Mol Pharm 2021;18:2777-85. [PMID: 34121410 DOI: 10.1021/acs.molpharmaceut.1c00326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chen KJ, Plaunt AJ, Leifer FG, Kang JY, Cipolla D. Recent advances in prodrug-based nanoparticle therapeutics. Eur J Pharm Biopharm 2021;165:219-43. [PMID: 33979661 DOI: 10.1016/j.ejpb.2021.04.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
8 Zhu S, Shen Q, Gao Y, Wang L, Fang Y, Chen Y, Lu W. Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor–SN38 Conjugates for Targeted Drug Accumulation. J Med Chem 2020;63:5421-41. [DOI: 10.1021/acs.jmedchem.0c00305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Chen J, He G, Xian G, Su X, Yu L, Yao F. Mechanistic biosynthesis of SN-38 coated reduced graphene oxide sheets for photothermal treatment and care of patients with gastric cancer. Journal of Photochemistry and Photobiology B: Biology 2020;204:111736. [DOI: 10.1016/j.jphotobiol.2019.111736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Li F, Huang Z, Chen H, Yan L, Li J, Su Y, Zhang Q, Huang Z, Zheng Y. Redox-sensitive lipophilic prodrugs: delivering unstable chemotherapeutant for improved cancer therapy. Drug Deliv 2019;26:1068-79. [PMID: 31735094 DOI: 10.1080/10717544.2019.1678696] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
11 Liu F, Li A, Li F, Li J, Yan L, Li F, Luo J, Huang Z, Zheng Y. Entrapping Instantly‐Cleaved CPT Prodrugs in Polymeric Micelles for CPT Delivery. ChemistrySelect 2019;4:12428-33. [DOI: 10.1002/slct.201903035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Si J, Zhao X, Gao S, Huang D, Sui M. Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin. International Journal of Pharmaceutics 2019;568:118499. [DOI: 10.1016/j.ijpharm.2019.118499] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]